Day: June 23, 2025

Preferred Bank Announces Approval of Stock Repurchase and Cash Dividend

Written by Customer Service on June 23, 2025. Posted in Dividend Reports And Estimates.

LOS ANGELES, June 23, 2025 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), one of the largest independent commercial banks in California, today reported that the Board of Directors has received regulatory approval to implement its recently announced $125 million stock repurchase plan which was approved by shareholders in May. Preferred Bank is not a Securities & Exchange Commission (“SEC”) registrant, therefore the Bank requires regulatory approval prior to repurchasing its own common stock. The Board of Directors has approved the first tranche of repurchases which will consist of $50 million in buybacks. The stock purchases will be made from time to time in the open market. In addition, the Board of Directors has declared a quarterly cash dividend to $0.75 per share, payable on July 22, 2025 to holders of record on July...

Finanskalender 2025 og 2026

Written by Customer Service on June 23, 2025. Posted in Public Companies.

BRØNDBYERNES I.F. FODBOLD A/SCVR-nr. 83 93 34 10 Brøndby, den 23. juni 2025 SELSKABSMEDDELELSE NR. 7/2025 Brøndbyernes IF Fodbold A/S – Finanskalender 2025 og 2026 Brøndbyernes IF Fodbold A/S har planlagt følgende datoer for meddelelser og ordinære generalforsamlinger i resten af 2025 og for 2026. 25. september 2025: Årsrapport 2024/25 for perioden 1. juli 2024 – 30. juni 2025 21. oktober 2025: Ordinær generalforsamling 5. marts 2026: Delårsrapport 1. halvår 2025 for perioden 1. juli 2025 – 31. december 2025 24. september 2026: Årsrapport 2025/26 for perioden 1. juli 2025 – 30. juni 2026 20. oktober 2026: Ordinær generalforsamling Brøndby IF Bestyrelsen InformationYderligere information om denne meddelelse kan fås hos administrerende direktør Ole Palmå på telefon 43 63 08 10.Attachment...

Worksport Reports Consecutive Months of Record-Breaking Revenues, Gross Margin Improves by 25%

Written by Customer Service on June 23, 2025. Posted in Public Companies.

Company Reports All-Time-High Revenue in May 2025 (Following Record April 2025 Sales) as Gross Margins Rise 25% from Q1 2025 Levels; Growth Momentum Expected to Continue West Seneca, New York, June 23, 2025 (GLOBE NEWSWIRE) — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S. based manufacturer and innovator of hybrid and clean energy solutions for the light truck, overlanding, and global consumer goods sectors, today announced that May 2025 sales reached $1.28 million, marking the Company’s second consecutive month of record-breaking revenue (non-audited). Gross Margins continue to improve notably, as Worksport’s Made-in-USA cover line continues to gain significant traction. Worksport’s April and May 2025 revenues alone have surpassed total Q1 2025 revenue, signaling strong momentum entering the second half of...

ECD Automotive Design Secures $500M Equity Facility to Fund a Bitcoin Treasury

Written by Customer Service on June 23, 2025. Posted in Public Companies.

$500M facility earmarked for the strategic accumulation of Bitcoin to serve as the Company’s primary reserve asset and for the funding of growth and general corporate purposes. The Company will grow its digital asset footprint beyond the recent BitPay relationship to unlock the crypto-native customer demographic. First 21 customers to purchase a vehicle with Bitcoin to receive $21,000 upgrade credit.KISSIMMEE, Fla. , June 23, 2025 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (NASDAQ: ECDA), the world’s largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs and Toyota FJs is thrilled to announce the signing of a $500M equity facility with ECDA Bitcoin Treasury LLC (the “Facility”). The proceeds of this strategic financing...

Anthony Pompliano Strikes $1 Billion Merger to Create ProCap Financial; Raises Over $750M in Largest Initial Fundraise in History for Public Bitcoin Treasury Company

Written by Customer Service on June 23, 2025. Posted in Mergers And Acquisitions.

ProCap Financial to strategically acquire bitcoin and generate revenue and profits from its bitcoin holdings Equity investors have immediate exposure to bitcoin based on structure of financing transactions Columbus Circle Capital Corp. I (NASDAQ: CCCM) to take ProCap Financial publicNew York, NY, June 23, 2025 (GLOBE NEWSWIRE) — American investor and entrepreneur Anthony Pompliano today announced that ProCap BTC, LLC, a bitcoin-native financial services firm, has entered into a definitive agreement for a business combination with Columbus Circle Capital Corp. I (NASDAQ: CCCM), a SPAC sponsored by a controlled subsidiary of Cohen & Company, Inc. At the closing of the proposed business combination, the combined company will operate as ProCap Financial, Inc., with up to $1 billion in bitcoin on its balance sheet. Entities...

Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update

Written by Customer Service on June 23, 2025. Posted in Earnings Releases And Operating Results.

Held Type C meeting with FDA on Planned New Drug Application (NDA) Submission, Including Clinical, Non-clinical, and Chemistry, Manufacturing, and Control (CMC) Requirements NDA On Track for Submission to FDA in First Half of Calendar 2025 NDA to be Supported by Data from Phase 3 STRIVE-ON Safety Trial, which Met Primary Endpoint and Provided Evidence of Clinical Benefit Compared to Orally Administered Nimodipine Secured Private Placement Financing of $15 Million in Upfront Gross Proceeds with the Potential to Receive up to an Additional $15 Million in Potential Warrant Exercise Proceeds for an Aggregate of Up to Approximately $30 Million in Potential Total Gross Proceeds PRINCETON, N.J., June 23, 2025 (GLOBE NEWSWIRE) — Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company...

Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger

Written by Customer Service on June 23, 2025. Posted in Public Companies.

A Strategic Move to Accelerate Market Reach for Innovative Pharmaceutical Patents on June 23, 2025NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) — Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical Inc. (“Impact BioMedical”) (NYSE American: IBO), a Texas based biopharmaceuticals developer listed on the New York Stock Exchange American (“Impact BioMedical”, together with Dr Ashleys, the “Parties”), are pleased to announce the execution of a merger and share exchange agreement (the “Merger Agreement”) on June 21, 2025 to enter into a strategic merger transaction (the “Transaction”). Upon closing of the Transaction, Dr. Ashleys will acquire Impact BioMedical through a reverse merger that will result in a newly formed combined entity (the “PubCo”) traded on the NYSE American under...

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

Written by Customer Service on June 23, 2025. Posted in Public Companies.

Vancouver, Canada, June 23, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the addition of Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel, as an additional clinical site for its ongoing Phase I/IIa clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This expansion follows the recent enrollment of the first patient in the trial, announced on June 5, 2025, marking a significant milestone in the development of CMND-100. The study at Tel Aviv Sourasky Medical Centerwill be led by Dr. David Zeltser,...

Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type 2 Diabetes in Preclinical Models

Written by Customer Service on June 23, 2025. Posted in Public Companies.

New findings demonstrated that a single dose of Rejuva was well tolerated in healthy animals, with no evidence of toxicity Rejuva-treated healthy animals exposed to a high fat diet were protected from weight gain and hyperglycemia Data reinforce advancement of RJVA-001 toward first-in-human studies; preliminary clinical data expected in 2026 BURLINGTON, Mass., June 23, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D), today announced new preclinical data from its Rejuva Smart GLP-1 pancreatic gene therapy platform at the American Diabetes Association’s (ADA) 85th Scientific Sessions. The abstract, titled “Single-Dose GLP-1-Based Pancreatic Gene Therapy Prevents Obesity...

Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy

Written by Customer Service on June 23, 2025. Posted in Public Companies.

12 of 13 participants maintained or lost weight at 3 months, with 6 of 13 losing additional weight after stopping GLP-1 therapy and undergoing Revita procedure Median weight remained stable through 3 months (0.46% / ~ 1 pound weight change within the margin of error for daily weight measurement), compared to expected 5–6% weight regain (10–15 pounds) after stopping GLP-1 therapy Revita continued to demonstrate excellent tolerability profile compared to GLP-1 drugs; treatment-emergent adverse effects were infrequent, mild, and transient Randomized Midpoint Cohort data expected in Q3 2025; Pivotal Cohort data anticipated in H2 2026 BURLINGTON, Mass., June 23, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root...

Day: June 23, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals